Home Tools
Log in
Cart

Search Result

Search Results for " cxc chemokine receptors "

20

Compounds

Cat No. Product Name Synonyms Targets
T1955 SB225002 CXCR
SB225002 is a potent and selective CXCR2 antagonist inhibiting interleukin IL-8 binding to CXCR2.
T3047 SRT3109 CXCR
SRT3109 is a CXCR2 ligand used in the treatment of chemokine mediated diseases and conditions.
T7681 AZD-5069 CXCR
AZD-5069 is an chemokine receptor 2 antagonist (CXCR2; IC50 = 0.79 nM).
T1739 WZ811 CXCR
WZ811 is a novel and effective small molecular CXCR4 antagonist (EC50: 0.3 nM).
T4163 Reparixin DF 1681Y,Repertaxin CXCR
Reparixin (Repertaxin) is a potent inhibitor of both CXCL8 receptors CXCR1/2, it inhibits weakly CXCR2-mediated cell migration (IC50=100 nM), whereas it strongly blocks CXCR1-mediated chemotaxis (IC50=1 nM).
T3992 MSX-122 MSX 122,MSX122 CXCR
MSX-122 is a novel small molecule and partial CXCR4 antagonist, with potent inhibition of CXCR4/CXCL12 actions(IC50 = 10 nM).
T17208 USL311 CXCR
USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4. USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing...
T5193 Danirixin GSK1325756 CXCR
Danirixin (GSK1325756) is a potent antagonist of CXCR2 that inhibits IL-8 binding to CXCR2 (IC50: 12.5 nM).
T10297L AMG 487 CXCR
AMG 487 is a potent and selective antagonist of chemokine (C-X-C motif) receptor 3 (CXCR3) which inhibits the binding of CXCL10 and CXCL11 to CXCR3 with IC50s of 8.0 and 8.2 nM, respectively.
T2477 UNBS5162 UNBS 5162,UNBS-5162 CXCR , Autophagy
UNBS5162 (UNBS-5162) is a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.
T9721 ML339 CXCR
ML339 a selective inhibitor of CXCR6(IC50 = 140 nM) with no response when screened against CXCR5 and CXCR4.
T4033 MSX-130 MSX 130 CXCR
MSX-130 is CXCR4 Antagonist.
T4032 MSX-127 MSX 127 CXCR
MSX-127 elicites positive response in peptide CXCR4.
TQ0174 Mavorixafor AMD-070 CXCR
Mavorixafor (AMD-070) is an effective and selective antagonist of CXCR4, with an IC50 value of 13 nM against CXCR4 125I-SDF binding. Mavorixafor inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells (IC...
T7499 TAK-779 Takeda 779 HIV Protease , CXCR , CCR
TAK-779 (Takeda 779) is an antagonist of chemokine receptor 5 (CCR5), CCR2b, and CXC chemokine receptor 3 (CXCR3).
T8497 SX-682 CXCR
SX-682 is a potent, selective and orally bioavailable inhibitor of CXCR1/2 ,has the potential to treat castration-resistant prostate cancer.
T16850 SB-265610 GSK-CXCR2 CXCR
SB-265610 (GSK-CXCR2) is a nonpeptide and allosteric CXCR2 antagonist. SB-265610 blocks rat cytokine-induced neutrophil chemoattractant-1 (CINC-1)-induced calcium mobilization and neutrophil chemotaxis (IC50s: 3.7 nM and...
T3396 Baohuoside I Icariside-II,Icariin-II Apoptosis , CXCR
Baohuoside I (Icariside-II) is a component of Epimedium koreanum, exhibits anti-inflammatory activity and anti-osteoporosis activities.
T11179 Elubrixin SB-656933 IL Receptor , CXCR
Elubrixin (SB-656933) inhibits neutrophil CD11b upregulation (IC50 of 260.7 nM) and shape change (IC50 of 310.5 nM). Elubrixin can be used for inflammatory diseases such as inflammatory bowel disease and airway inflammat...
T7130 Navarixin MK-7123,SCH 527123 CXCR
Navarixin (MK-7123)(SCH527123) is a novel, selective CXC chemokine receptor 2(CXCR2) antagonist that inhibits neutrophil activation and modulates neutrophil trafficking in animal models, characteristics that may be benef...
1 2
TargetMol